Article
Splenic granulopoiesis and S100A9 drive resistance to checkpoint inhibitors conferred by liver metastases
2025-10-01
Abstract excerpt
Here, we investigate why liver metastases reduce the efficacy of immune checkpoint inhibitors (CPI). The poor prognosis of patients with liver metastases is associated with a systemic increase in neutrophils. Using experimental models, we confirm that mice with liver metastases respond poorly to CPI, have elevated neutrophils and suppress the response of subcutaneous lesions to CPI. We demonstrate that liver metas...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b8d102b1-f2cb-51e0-8186-89e9a85836a9
- DOI
- 10.1101/2025.09.30.679035
